Industry Warily Eyes New Medicare Drug Plan  

Oleh:

Vastag, Brian

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 24 no. 2 (Feb. 2006), page 120.
Topik: INDUSTRY; industry warily; medicare; drug plan

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.4 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

On january 1 a new subsection of medicatre, known as apart D, was launched under intense industry scrunity. Biotech companies whose revenue depends for a non negligible part, on government reinburment of prescription drugs for citizens 65 years of age and older, have been pushing to get their innovative product covered. And although industry has been coy about commenting on the new rules, companies are worried that the plan will not cover drugs for rare disease and will reduce the incentive for industry to innnovative.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali